• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Scynexis Inc (NQ: SCYX )

    1.270 -0.020 (-1.56%)
    Streaming Delayed Price Updated: 9:47 AM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Scynexis Inc

    < Previous 1 2 3 4 5 6 Next >
    SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    ROSEN, INVESTOR RIGHTS LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SCYNEXIS, Inc. (SCYX) Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    NASDAQ:SCYX Investor Notice: Investigation over Possible Securities Laws Violations by SCYNEXIS, Inc.
    San Diego, CA -- (SBWIRE) -- 11/02/2023 -- SCYNEXIS, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    Scynexis, Inc. (SCYX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Scynexis, Inc.
    From Robbins LLP
    Via Business Wire
    SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SCYNEXIS, Inc. (SCYX) Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm, P.A.
    Via Business Wire
    SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of SCYNEXIS, Inc. (SCYX) Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    SCYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against SCYNEXIS, Inc.
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of SCYNEXIS, Inc. (SCYX) Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    SCYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against SCYNEXIS, Inc.
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Scynexis, Inc. (SCYX)
    From Kirby McInerney LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating SCYNEXIS, Inc. on Behalf of Scynexis Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    The Law Offices of Frank R. Cruz Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Gold Moves Lower; TransCode Therapeutics Shares Surge
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    The Law Offices of Frank R. Cruz Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Nasdaq Turns Higher; SCYNEXIS Shares Plunge
    U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. 
    Via Benzinga
    Why Are Antifungal Focused Scynexis Stock Plunging Today?
    Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga 
    Via Benzinga
    U.S. Stocks Open Lower; Chicago Fed Index Falls In August
    U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.